These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29460498)

  • 1. The molecular epidemiology of Huntington disease is related to intermediate allele frequency and haplotype in the general population.
    Kay C; Collins JA; Wright GEB; Baine F; Miedzybrodzka Z; Aminkeng F; Semaka AJ; McDonald C; Davidson M; Madore SJ; Gordon ES; Gerry NP; Cornejo-Olivas M; Squitieri F; Tishkoff S; Greenberg JL; Krause A; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2018 Apr; 177(3):346-357. PubMed ID: 29460498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Huntington disease in the South African population occurs on diverse and ethnically distinct genetic haplotypes.
    Baine FK; Kay C; Ketelaar ME; Collins JA; Semaka A; Doty CN; Krause A; Greenberg LJ; Hayden MR
    Eur J Hum Genet; 2013 Oct; 21(10):1120-7. PubMed ID: 23463025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High frequency of intermediate alleles on Huntington disease-associated haplotypes in British Columbia's general population.
    Semaka A; Kay C; Doty CN; Collins JA; Tam N; Hayden MR
    Am J Med Genet B Neuropsychiatr Genet; 2013 Dec; 162B(8):864-71. PubMed ID: 24038799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of intermediate CAG alleles of the HTT in the general population of Rio de Janeiro, Brazil, in comparison with a sample of Huntington disease-affected families.
    Apolinário TA; da Silva IDS; Agostinho LA; Paiva CLA
    Mol Genet Genomic Med; 2020 Apr; 8(4):e1181. PubMed ID: 32067426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The targetable A1 Huntington disease haplotype has distinct Amerindian and European origins in Latin America.
    Kay C; Tirado-Hurtado I; Cornejo-Olivas M; Collins JA; Wright G; Inca-Martinez M; Veliz-Otani D; Ketelaar ME; Slama RA; Ross CJ; Mazzetti P; Hayden MR
    Eur J Hum Genet; 2017 Feb; 25(3):332-340. PubMed ID: 28000697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Comprehensive Haplotype-Targeting Strategy for Allele-Specific HTT Suppression in Huntington Disease.
    Kay C; Collins JA; Caron NS; Agostinho LA; Findlay-Black H; Casal L; Sumathipala D; Dissanayake VHW; Cornejo-Olivas M; Baine F; Krause A; Greenberg JL; Paiva CLA; Squitieri F; Hayden MR
    Am J Hum Genet; 2019 Dec; 105(6):1112-1125. PubMed ID: 31708117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Huntington disease.
    Kay C; Hayden MR; Leavitt BR
    Handb Clin Neurol; 2017; 144():31-46. PubMed ID: 28947124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REVIEW-ARTICLE Intermediate alleles of Huntington's disease HTT gene in different populations worldwide: a systematic review.
    Apolinário TA; Paiva CL; Agostinho LA
    Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28387881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Junctophilin 3 (JPH3) expansion mutations causing Huntington disease like 2 (HDL2) are common in South African patients with African ancestry and a Huntington disease phenotype.
    Krause A; Mitchell C; Essop F; Tager S; Temlett J; Stevanin G; Ross C; Rudnicki D; Margolis R
    Am J Med Genet B Neuropsychiatr Genet; 2015 Oct; 168(7):573-85. PubMed ID: 26079385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency and distribution of polyQ disease intermediate-length repeat alleles in healthy Italian population.
    Mongelli A; Magri S; Salvatore E; Rizzo E; De Rosa A; Fico T; Gatti M; Gellera C; Taroni F; Mariotti C; Nanetti L
    Neurol Sci; 2020 Jun; 41(6):1475-1482. PubMed ID: 31940111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTT haplotypes contribute to differences in Huntington disease prevalence between Europe and East Asia.
    Warby SC; Visscher H; Collins JA; Doty CN; Carter C; Butland SL; Hayden AR; Kanazawa I; Ross CJ; Hayden MR
    Eur J Hum Genet; 2011 May; 19(5):561-6. PubMed ID: 21248742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic aspects of Huntington's disease in Latin America. A systematic review.
    Castilhos RM; Augustin MC; Santos JA; Perandones C; Saraiva-Pereira ML; Jardim LB;
    Clin Genet; 2016 Mar; 89(3):295-303. PubMed ID: 26178794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAG size-specific risk estimates for intermediate allele repeat instability in Huntington disease.
    Semaka A; Kay C; Doty C; Collins JA; Bijlsma EK; Richards F; Goldberg YP; Hayden MR
    J Med Genet; 2013 Oct; 50(10):696-703. PubMed ID: 23896435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancestral differences in the distribution of the delta 2642 glutamic acid polymorphism is associated with varying CAG repeat lengths on normal chromosomes: insights into the genetic evolution of Huntington disease.
    Almqvist E; Spence N; Nichol K; Andrew SE; Vesa J; Peltonen L; Anvret M; Goto J; Kanazawa I; Goldberg YP
    Hum Mol Genet; 1995 Feb; 4(2):207-14. PubMed ID: 7757069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis and prevalence of Huntington disease in northwestern Iran.
    Shekari Khaniani M; Aob P; Ranjouri M; Mansoori Derakhsan S
    Turk J Med Sci; 2017 Dec; 47(6):1880-1884. PubMed ID: 29306253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.
    Ma M; Yang Y; Shang H; Su D; Zhang H; Ma Y; Liu Y; Tao D; Zhang S
    J Neurol Sci; 2010 Nov; 298(1-2):57-60. PubMed ID: 20864123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracing the mutated HTT and haplotype of the African ancestor who spread Huntington disease into the Middle East.
    Squitieri F; Mazza T; Maffi S; De Luca A; AlSalmi Q; AlHarasi S; Collins JA; Kay C; Baine-Savanhu F; Landwhermeyer BG; Sabatini U; Hayden MR
    Genet Med; 2020 Nov; 22(11):1903-1908. PubMed ID: 32661355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.
    Kay C; Collins JA; Skotte NH; Southwell AL; Warby SC; Caron NS; Doty CN; Nguyen B; Griguoli A; Ross CJ; Squitieri F; Hayden MR
    Mol Ther; 2015 Nov; 23(11):1759-1771. PubMed ID: 26201449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Molecular Findings of Intermediate Allele Carriers in the HTT Gene from the Mexican Mestizo Population.
    Ramírez-García MÁ; Dávila-Ortiz de Montellano DJ; Martínez-Ruano L; Ochoa-Morales A; Romero-Hidalgo S; Zenteno JC; Yescas-Gómez P
    Neurodegener Dis; 2022; 22(1):34-42. PubMed ID: 35926480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of DNA sequence and CAG size to mutation frequencies of intermediate alleles for Huntington disease: evidence from single sperm analyses.
    Chong SS; Almqvist E; Telenius H; LaTray L; Nichol K; Bourdelat-Parks B; Goldberg YP; Haddad BR; Richards F; Sillence D; Greenberg CR; Ives E; Van den Engh G; Hughes MR; Hayden MR
    Hum Mol Genet; 1997 Feb; 6(2):301-9. PubMed ID: 9063751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.